Uzbekistan buduje ambicje farmaceutyczne, inwestując 1,2 mld euro w centrum produkcji i eksportu

euronews (po polsku)

Uzbekistan buduje ambicje farmaceutyczne, inwestując 1,2 mld euro w centrum produkcji i eksportu  Uzbekistan dynamicznie rozwija swój sektor farmaceutyczny za sprawą Tashkent Pharma Park – projektu o wartości 1,2 mld euro łączącego badania, logistykę, produkcję i szkolenia. Ponieważ Europa dąży do dywersyfikacji łańcuchów dostaw leków, kraj ten staje się strategicznym partnerem.   We współpracy z Agency of Information and Mass Communications of Uzbekistan  CZYTAJ WIĘCEJ : http://pl.euronews.com/2025/06/24/uzbekistan-buduje-ambicje-farmaceutyczne-inwestujac-12-mld-euro-w-centrum-produkcji-i-eksp  Zasubskrybuj nasz kanał.Euronews jest dostępny na Dailymotion w 12 językach

Transcript

00:00Uzbekistan

00:05Jest to becoming a regional hub

00:07for pharmaceutical production

00:09and innovation.

00:10At the heart of it,

00:11a new pharma park

00:13in the country's capital,

00:14bringing together R&D,

00:16logistics

00:17and training.

00:18What could it mean for Europe

00:20as it diversifies

00:22critical medicine supplies?

00:27Hello and welcome to the program.

00:29Uzbekistan will be producing

00:31440 million euros

00:33worth of pharmaceutical products

00:35a year by the end of 2025,

00:38with exports making up

00:39just over half that value.

00:41The new 1.2 billion euro

00:44Tashkent Pharma Park

00:46will drive further growth

00:48while also creating

00:4911,000 new jobs.

00:51Take a look at this.

00:53Spread over 1.9 million square metres,

01:02the Tashkent Pharma Park,

01:03when complete,

01:04is set to turbocharge

01:06the sector's expansion.

01:08A hub for distributing pharmaceutical products

01:11is already up and running.

01:14The products come from many countries,

01:18most of them from Europe,

01:20some of them from China and India

01:21and other countries.

01:23And we have around 60 to 70 million packs

01:26coming and going each month.

01:31Around 400 workers keep things moving here,

01:34with products distributed all over Uzbekistan.

01:37In the future,

01:39it's set to become an export hub

01:41for Central Asia, too.

01:44Within a few years,

01:45we plan to expand

01:46from zero to 50 million dollars

01:48of export.

01:49We have already signed

01:50a few contracts

01:51with the major players from Europe

01:52and we are keen

01:53to see other players to come.

01:57Alongside logistics,

01:58the new Pharma Park

02:00will also have a centre

02:01for biotech

02:02and genome research,

02:04a technical university

02:06and manufacturing facilities.

02:08And all within a free economic zone,

02:11offering tax incentives.

02:15There will be huge integration

02:16of all the pillars of the industry

02:18and that's the key.

02:19On top of that,

02:20we are also focusing

02:21on not only developing

02:22the local companies,

02:23but also we are trying

02:24to attract foreign investors.

02:26The reason is different methodology,

02:28different experience

02:29or different skills

02:30and when you put all of them together,

02:32there will be a synergy.

02:33Established pharmaceutical companies

02:37are also driving up growth

02:39in the sector.

02:40This manufacturer

02:41is one of Uzbekistan's largest,

02:44making over 180 types of products,

02:47including tablets and ointments.

02:50It already exports

02:51to 11 countries.

02:53We want to expand our company

02:56to some other countries also,

02:59like Azerbaijan,

03:01some European countries,

03:02Turkey

03:03and some African markets.

03:05We have experience,

03:06we have R&D centre,

03:07we know how to do it,

03:09so it's a good reason

03:10to expand the business

03:12and to supply the high-effective product

03:14in that market also.

03:16It's this kind of growth

03:18that Uzbekistan's looking to replicate

03:20as part of its vision

03:22for the wider sector.

03:24By implementing international standards,

03:27we'll have more opportunity

03:28to go to European countries

03:30or America

03:31or other countries.

03:32This is what we are really

03:33right now working on.

03:34And we also have to prove

03:36that we are strong in R&D sector.

03:38and we are also doing,

03:40as an example,

03:41clinical trials in Uzbekistan.

03:43All paving the way

03:44for this Central Asian country

03:46to claim its place

03:47on the global pharmaceutical map.

03:54Let's speak now to Oybek Shikov

03:56from the Europe Uzbekistan Association

03:58for Economic Cooperation,

04:00who's in Brussels.

04:01What do you think

04:02this all means for Europe then?

04:04Of course,

04:05the deregulation

04:06of Uzbekistan's pharmaceutical sector

04:09bringing to the WTO standards,

04:11the production requirements as well,

04:14means that European companies

04:15have more opportunities

04:16to invest in Uzbekistan,

04:18especially for generic medicines,

04:20potential production

04:21that ultimately might be able

04:23to expand into exports

04:25back to the European Union.

04:27But what about challenges

04:28and how can they be navigated?

04:30Of course,

04:31the pharmaceutical sector

04:32is a very complex

04:33and very regulated sector.

04:34Ensuring high quality

04:35is extremely important.

04:37And I believe that

04:38the dialogue with the government

04:39that is taking place

04:41also through euros

04:42is extremely important element

04:44in that direction.

04:45Thank you very much indeed

04:46for your insights.

04:47Well, that's all we've got time

04:48for in this edition,

04:49but there's more business news

04:50at Euronews.com.

04:52Thanks for watching

04:54and bye for now.

Category

Transcript

Recommended